Signal active
Bio
Roger Jeffs retired as President and co-CEO at United Therapeutics in 2016 after a successful 18-year tenure. Dr. Jeffs joined United Therapeutics Corporation during its start-up phase in 1998 as Director of Research, Development, and Medical, and served as the company’s President and Chief Operating Officer from 2001 to 2014 and President & co-CEO from 2015-2016. While at United Therapeutics, Dr. Jeffs helped lead the IPO, oversaw the clinical development and regulatory approval of six products for rare diseases, and managed the commercial effort that led to >20% CAGR and $1.5B annual revenue run rate. United Therapeutics was consistently recognized as one of the fastest growing companies and best places to work during his tenure. Dr. Jeffs received the 2015 Wings of Hope Award from the Solving Kids’ Cancer organization in “recognition of his visionary leadership in advancing cancer research while prioritizing the lives of children”. Dr. Jeffs previously held positions at Amgen, Inc. and Burroughs Wellcome Co where he held roles in clinical development. Dr. Jeffs holds an undergraduate degree in chemistry from Duke University and a Ph.D. in pharmacology from the University of North Carolina School of Medicine. Dr. Jeffs previously served on the Board of Directors for United Therapeutics, Dova Pharmaceuticals, and Sangamo Therapeutics and currently serves on the Boards of Albireo Pharma, and Axsome Therapeutics.
Location
Chapel Hill, North Carolina, United States, North America
Social
Primary Organization
2004
101-250
Biotechnology, Health Care, Biopharma, Therapeutics, Nanotechnology
Jobs history
3
Liquidia Technologies
Chief Executive Officer (CEO)
2022 - Current
Liquidia Technologies
Board Member
2020 - 2021
Kriya Therapeutics
Co-Founder & Vice Chairman
2019 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Roger Jeffs is the Chief Executive Officer (CEO) at Liquidia Technologies, based in United States, North America. With a background in Biotechnology, Roger Jeffs has a rich history of leadership and innovation. Roger Jeffs studied BA Chemistry @ Duke University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
Paul Manning
President,Chairman & Chief Executive Officer
Investment portfolio
1
1
Personal investment
1
Annouced Date | Organization Name | Funding Round | Money Raised |
---|---|---|---|
Apr 13, 2021 | Liquidia Technologies | Post-IPO Equity - Liquidia Technologies | 21.7M |
Partner investment
0
There is no partner investment available on this profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.